HEPATOCELLULAR CANCER
Clinical trials for HEPATOCELLULAR CANCER explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CANCER trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a viagra drug help fight liver cancer? new trial tests unlikely combo
Disease control TerminatedThis phase 2 trial tested a combination of three drugs—nivolumab (an immunotherapy), tadalafil (commonly used for erectile dysfunction), and vancomycin (an antibiotic)—in adults with liver cancer or liver metastases from colorectal or pancreatic cancers that had not responded to …
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 20:47 UTC
-
Experimental cancer drug TAK-500 tested in 61 patients – trial halted early
Disease control TerminatedThis study tested a new drug called TAK-500, given alone or with another immunotherapy (pembrolizumab), in 61 adults with advanced solid tumors like pancreatic, liver, and lung cancer. The goal was to check safety and see if the drug could shrink tumors. The trial was terminated …
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Gene mapping study aims to match GI cancer patients with tailored therapies
Knowledge-focused TerminatedThis study looked at genetic changes in tumors from 565 people with advanced cancers of the stomach, liver, bile ducts, gallbladder, or pancreas. The goal was to see how often these changes could be targeted with specific drugs and whether using genetic information helped doctors…
Matched conditions: HEPATOCELLULAR CANCER
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:07 UTC